Zeo ScientifiX (ZEOX) Retained Earnings (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Retained Earnings of -$68.7 million for Q2 2026, down 5.99% year-over-year from -$73.1 million in Q2 2025, and little changed quarter-over-quarter from -$68.6 million in Q1 2026.
Zeo ScientifiX (ZEOX) Retained Earnings (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Retained Earnings history runs 15 years deep, the most recent figure standing at -$68.7 million for Q2 2026.
- In Q2 2026, Retained Earnings fell 5.99% year-over-year to -$68.7 million; the TTM figure through Apr 2026 stood at -$68.7 million (down 5.99% YoY), while the FY2025 annual figure was $66.3 million, up 206.58% from the prior year.
- Retained Earnings for Q2 2026 stood at -$68.7 million, roughly flat from -$68.6 million in the prior quarter.
- The five-year high for Retained Earnings was $66.3 million in Q4 2025, with the low at -$68.7 million in Q2 2026.
- The 5-year median for Retained Earnings is -$49.0 million (2022), against an average of -$8.9 million.
- Peak annual rise in Retained Earnings reached 211.36% in 2023, while the deepest fall reached 239.02% in 2023.
- Zeo ScientifiX's Retained Earnings stood at -$50.5 million in 2022, then surged by 211.36% to $56.3 million in 2023, then slumped by 210.58% to -$62.2 million in 2024, then soared by 206.58% to $66.3 million in 2025, then plunged by 203.66% to -$68.7 million in 2026.
- Business Quant data shows ZEOX's Retained Earnings at -$68.7 million in Q2 2026, -$68.6 million in Q1 2026, and $66.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 69.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -68.73 Mn |
| Jan 31, 2026 | -68.59 Mn |
| Oct 31, 2025 | 66.30 Mn |
| Jul 31, 2025 | 64.60 Mn |
| Apr 30, 2025 | -64.85 Mn |
| Jan 31, 2025 | -63.46 Mn |
| Oct 31, 2024 | -62.21 Mn |
| Jul 31, 2024 | 59.53 Mn |
| Apr 30, 2024 | 58.24 Mn |
| Jan 31, 2024 | -58.55 Mn |
| Oct 31, 2023 | 56.26 Mn |
| Jul 31, 2023 | -56.42 Mn |
| Apr 30, 2023 | -54.80 Mn |
| Jan 31, 2023 | 52.00 Mn |
| Oct 31, 2022 | -50.52 Mn |
| Jul 31, 2022 | -47.50 Mn |
| Apr 30, 2022 | 39.42 Mn |
| Jan 31, 2022 | 38.88 Mn |
| Oct 31, 2021 | 37.83 Mn |
| Jul 31, 2021 | -40.67 Mn |